BioPharma
26 November, 2021 | Friday | News
First GMP Production at 24,000L Line of MFG5 Facility Successfully Completed at WuXi Biologics
WuXi Biologics (“WuXi Bio”) (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has successfully completed the first GMP production at the new 24,0...
Lab
22 November, 2021 | Monday | News
Labcorp to Expand Nonclinical Development Testing Capabilities
Transaction Expands Capacity and Strengthens Full-Service Testing Portfolio -Labcorp a leading global life sciences company, today announced that it has entered into a definitive agreement to acq...
BioTech
26 November, 2021 | Friday | News
Sartorius significantly expands activities in South Korea
In the country's biopharma hub Songdo in Incheon, the company plans to launch cell culture media production and to assemble sterile systems for efficient and flexible manufacturing of biopharmaceuticals, among ...
Contract Services
25 November, 2021 | Thursday | News
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, and Environmental Impact Acquisitio...
Consumer Health
26 November, 2021 | Friday | News
Merck Survey: "Europeans' perception of health two years after the start of Covid 19"
The study "Merck Survey: "Europeans' perception of health two years after the start of Covid 19" was conducted in 10 European countries Almost a quarter of Europeans say they have reduced their alc...
White Paper
05 August, 2021 | Thursday | News
Strike the Right Balance between Compliance and Quality
Product Spot Light
19 November, 2021 | Friday | News
Lunit's AI Software for Breast Cancer Detection, Wins FDA Clearance
Premium Article
18 November, 2021 | Thursday | Opinion
Regulations in Healthcare: Complying in the Cloud
Bio Invest
24 November, 2021 | Wednesday | News
Neurophth Raised Over $60 Million USD in Series-C Financing to Advance Gene Therapies
Biopharma APAC Infomercial
Most Read
- Avantor® Announces Investment in Hydration Capabilities to Address Growing Demand for Biologics
- WuXi Biologics Received First Manufacturing License from Japan
- Merck and Universal Agree on the large-scale production of a new pediatric medication.
- AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics
- Zelgen and 111, Inc. to Develop a New Management Platform for Liver Cancer Patients in China
- Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy
- Eisai and FUJI YAKUHIN will provide new treatment options for hyperuricemia and gout in Five ASEAN Countries
- BioMed X & Merck KGaA, Darmstad Launch New Research Program in Oncology
- CIL is Now Offering Cannabis Standards for MS-based Testing
Bio Jobs
- Step-by-step breakdown: How to write a strong resume
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Find your Job at Eppendorf
- Thermo Fisher Scientific - Singapore is hiring for Account Manager | Apply Now!
- Healthcare and Technology to remain key recruiting sectors for India's recovery in 2021
News
Editor Picks
